Rose Beck
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Immune Cell Function and Interaction, Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → An update on Burkitt lymphoma: a review of pathogenesis and multimodality imaging assessment of disease presentation, treatment response, and recurrence(2019)130 cited
- → Repression of GSK3 restores NK cell cytotoxicity in AML patients(2016)112 cited
- → ERK Signaling Is Essential for Macrophage Development(2015)75 cited
- → Detection of Mature T-Cell Leukemias by Flow Cytometry Using Anti-T-Cell Receptor V b Antibodies(2003)59 cited
- → Detection of Mature T-Cell Leukemias by Flow Cytometry Using Anti–T-Cell Receptor VβAntibodies(2003)57 cited
- → The Notch Ligands Jagged2, Delta1, and Delta4 Induce Differentiation and Expansion of Functional Human NK Cells from CD34+ Cord Blood Hematopoietic Progenitor Cells(2009)51 cited
- → Biologic predictors in follicular lymphoma: Importance of markers of immune response(2007)49 cited
- → Aberrant Notch Signaling in the Bone Marrow Microenvironment of Acute Lymphoid Leukemia Suppresses Osteoblast-Mediated Support of Hematopoietic Niche Function(2016)47 cited
- → Interference of Therapeutic Monoclonal Antibodies With Routine Serum Protein Electrophoresis and Immunofixation in Patients With Myeloma(2018)46 cited
- → Significance of the absolute lymphocyte/monocyte ratio as a prognostic immune biomarker in newly diagnosed multiple myeloma(2017)46 cited